Excerpt: Pursuant to Rules X and XI of the U.S. House of Representatives, the Committee is examining an incident last month at the Centers for Disease Control and Prevention (CDC) involving the handling of anthrax specimens. As part of its oversight and in preparation for an upcoming hearing, the Committee is gathering pertinent background information and documents related to biosafety issues and the CDC laboratories.
21 C, The Coalition For 21st Century Patent Reform American Bankers Association
AEC Science & Technology, LLC Alliance for Water Efficiency (AWE)
To read the letter from HHS, click here. To read an attachment to the letter, click here.
American Chemistry Council Chamber of Commerce of the United States of America
Exerpt: As you know, Section 1342 of the Patient Protection and Affordable Care Act (PPACA, P.L. 111-148) directs the Secretary of Health and Human Services (HHS) to operate a risk corridor program to limit the profits and losses of qualified health plans in the individual and small group markets. However, the provision does not specify a source of funding for the program.